Gain visibility and control over your compliance processes with ease! Our integrated GDPR solution includes consent management, data discovery, documentation, audit logs, assessments, people and customer profiles, and much more. We give you a practical approach to GDPR and "Privacy by design". Get also an award-winning access portal that supports secure Single Sign-On access of data and easy setup of security policies. Mesier, The holistic approach to Cloud governance! Currently, we are 10 highly motivated people with extensive experience in making successful software. Let's talk!

FF Rollerskis AS – Bringing the Real Skiing Feeling to Asphalt FF Rollerskis AS is a Norwegian sports tech company redefining how athletes train off-season by designing and manufacturing world-leading roller skis. Founded by Henrik Lindhagen — skier, inventor, and innovator — our goal is simple: recreate the authentic feeling of skiing on snow, even on asphalt. Traditional roller skis are often stiff, unforgiving, and prone to cause strain or injury due to excessive vibration and poor flexibility. At FF Rollerskis, we’ve reengineered the roller ski from the ground up. Our unique floating fork suspension system and custom-developed rubber compounds drastically reduce vibration while preserving the natural flex and responsiveness of winter skis. The result? Roller skis that feel like the real thing. Our products include the FF V Pro Classic and FF Pro Skate, both equipped with V-groove wheels that enhance directional stability and simulate the resistance of groomed ski tracks. These wheels — along with advanced frame engineering — offer unparalleled ski feel, helping athletes maintain and refine technique throughout the off-season. Our Active series and Junior models make the FF experience accessible for younger athletes and recreational users alike. What sets FF Rollerskis apart: True ski feel on asphalt, with flex and vibration damping unmatched in the market. V-groove wheels that guide the ski naturally, improve control, and make skiing safer — especially for classic technique. Used by top athletes, including members of the Norwegian National Cross-Country Team and elite junior skiers. Only FIS-approved rollerski brand globally. Developed and tested in Norway — under real-world Nordic conditions. We’re committed to environmental responsibility and local production. All development and testing is done in Norway, and our goal is to bring the full manufacturing process home, enabling shorter supply chains, lower emissions, and job creation. Beyond just equipment, FF Rollerskis is building a movement. We offer a 100% satisfaction guarantee, provide free lifetime checkups (only pay for parts), and work closely with ambassadors and users to continuously improve our designs. Our customer base spans from beginners seeking safe, stable skis — to elite athletes demanding the highest performance. Whether you’re training for the World Cup, prepping for your first ski marathon, or looking for a smooth ride on summer roads, FF Rollerskis delivers the experience you’ve been missing. It’s not just about equipment — it’s about keeping the skiing spirit alive all year long. Visit us at www.ffskis.com Learn more: www.ffskis.com Learn more: ffskis.com Mail: henrik@ffskis.com Mobile: +47 95 88 70 70

Bile duct cancer is an aggressive form of cancer with an extremely poor overall five-year survival rate of just 2-5 %. Classified as an orphan disease, annual incidence in Europe and the United States of 15-22,000 patients, and a significantly higher incidence in Asia, makes it a major player and the deadliest of the gastrointestinal cancers. Only a small number of patients are eligible for a complete surgical resection by local resection or liver transplantation, and more than 50% of these relapse. The vast majority are treated by gemcitabine-based palliative chemotherapy with a life expectancy of 11 months, and five-year survival rate of zero %. Thus, there is an urgent and unmet medical need to develop new and better treatment strategies for these patients. The innovations developed by Seald are a result of adopting a multidisciplinary approach to the diagnosis and treatment of bile duct cancer, based on extensive drug sensitivity assays on living cancer cells, molecular biomarkers, DNA sequencing, extensive bioinformatics analyses and zebrafish models. Sealds’s holistic approach is unique with possible modes of action that can be used on other solid cancers. Our technology includes drug repurposing and innovation on new medical substances, diagnostics and methodology. The stipulated pharma market globally is USD 2.1-4.2 billion, in addition to the markets for diagnostics and platform technology

Biozep is discovering and developing first-in-class drug products for the treatment of severe eye diseases which can lead to vision loss and where it is a high unmet medical need. Biozep has discovered novel drug substances based on bioactive lipids which modulate central pathways involved in the pathogenesis of eye diseases. Targets and biomarkers are identified based on a system biology approach combined with in-depth knowledge about bioactive lipids, their endogenous synthesis and mechanisms of action. Biozep has made a prototype drug product based on our lead compound for topical administration and the product will be tested in animal models in 2018. Our goal is to start clinical studies in 2020. Biozep is a company depending on both internal and external resources. Biozep has established its own laboratory in Oslo in order to do synthesis, purification, quality control and chemical development in-house. The biological testing of the drug substances is performed in collaboration with carefully selected contract research organizations both in Europe and the USA. In order to reach the market as fast as possible and to reduce risk, Biozep will seek strategic partnerships early in the drug development phase. Biozep seeks partners with complementary competence and with resources to conduct clinical trials and with market access. We are already in dialogue with potential partners and hope to sign an agreement in 2018-19.

New drugs for treating diseases of Down syndrome. More than 1% of the global GDP is spent on nursing demented people, and the number requiring nursing will triple within 2050. The disease is progressive, leading to death. There is no current cure available, only symptomatic treatments. Individuals born with Down syndrome have a more than 10x risk of developing dementia as well as a host of other diseases including diabetes. Our drug target, DYRK1A is an enzyme found on chromosome 21, and is considered a key factor determining developmental and medical challenges faced by individuals with Down. The enzyme interacts with multiple biological mechanisms involved in Alzheimer’s and autoimmune diseases. Advanced drug designUsing advanced drug design technologies, we have designed a potent DYRK1A inhibitor drug, PST-900. A use and substance of matter patent have been applied for. The company is currently working on chemical Lead Optimisation with 8 full-time medicinal chemists contracted.Financing and milestonesThe Company raised NOK 5 million in 2015 and 8.8 MNOK in 2016/2017, matching non-dilutive research (BIA) and business grants (Innovation Norway). We demonstrated Proof of Principle in a model system for Alzheimer’s disease in 2Q2016. We have also demonstrated that our drug is capable of reversing diabetes in an animal model. Together with clinical and regulatory advisors, we have identified an important unmet need for a drug to treat newly diagnosed diabetes. We will use this indication to quickly progress to market and from there develop analogous drug molecules in Alzheimer’s disease, focused especially in Down syndrome. Funding soughtThe current funding round will raise 15+ MNOK to fund the progression to the final Development Candidate during 2018. Following this, further funding will be sought to perform toxicology/safety and Phase 1 clinical studies. A highly experienced teamThe team behind Pharmasum Therapeutics have broad, international pharmaceutical and biotechnology experience, and is supported by an excellent group of advisors. Anders Fugelli, Ph.D., CEO. John Sigurd Svendsen, Ph.D., CSO. Pauline Stewart-Long, Ph.D. Project Management. Henning Mork, CFO. Board of Directors: Andrew Parsons, PhD. Øystein Soug, MSc. Mark Treherne, PhD, John Sigurd Svendsen, PhD.

LifeTools AS develops digital tools for people with complex needs within the fields of communication, cognition, and challenged behavior. We put the user first and develop dynamic systems with high flexibility based on the unique user's needs. The network around the user will have digital tools to observe, build and publish expressions, routines, and activities into our systems, and use this information back into the interaction with the user. This gives a better foundation in communication and helps increase the quality of life for the user. Our philosophy is to use "everyday technology" such as tablets/phones and cloud-based solutions and develop highly intuitive and dynamic tools for the network. Users (people with special and complex needs) therefore do not need to acquire skills or knowledge in order to use our systems. This makes it easier for those who have great cognitive challenges to make use of our technological solutions.

LangO is changing the way companies deliver English language training to their employees online. We do this through a blended learning solution; a combination of live virtual lessons (Group Live Lessons and One-to-One) complemented by our on-demand micro-learning activities. Our responsive web app brings in the best-qualified teachers from around the world, custom-made LangO lesson content based on client's needs, and a scalable tech stack enabling employees to learn effectively on any device, at any time.

Nordic Electrofuel offers a solution for the rapid transition from fossil to renewable electrical energy for all transport sectors. It is based on the conversion of renewable electric energy into liquid electro-fuels that can be as easily transported, stored, and used as conventional fossil hydrocarbons. It also provides a good solution to distribute and store stranded electrical energy. PTL (Power To Liquid) has been considered too expensive, but with the low electricity price in Norway and new efficient processing and upgrading solutions, it has become commercially feasible. Electrification of transportation is required to avoid catastrophic climate change. Battery- or cable-electric solutions are not feasible for transport like aviation and long-distance marine transport. Liquid energy carriers such as biofuels are desperately needed but limited. The fuel is free of sulfur and can therefore be used maritime industry as a fuel after 2022. The fuel emits much fewer particles and aromatics than conventional fossil fuel, so it also solves the local pollution problem. Competitive advantages: • Norway’s low electricity price from hydro and lately also wind power. • 20 - 30 % lower electricity consumption than with existing technology • Lower production price than advanced biofuels • Agreements in place for a site at Herøya, which has all utilities (cooling water, cheap renewable electricity, etc.) and processing expertise available. • About the same source to shaft efficiency as hydrogen, but with much lower total CAPEX due to no investment in distribution systems and engines.

BusinessClass.com is a sophisticated travel tech startup. Our vision is to become the global leader in premium travel by offering the best travel search, the best travel offers, as well as world-class reviews and other inspirational content. BusinessClass.com is targeting the more quality-minded travellers who want the best travel products at the best possible prices. BusinessClass.com is suitable for both corporate & leisure travel, offering top-quality airline tickets and accommodation. The team and advisers at BusinessClass.com have extensive travel tech industry knowledge. Founder Jason Eckhoff was EY Entrepreneur Of The Year in 2013 when his first online travel company had beaten 28.000 growth companies over a 4-year period. BusinessClass.com is (other than the founder/CEO) backed by a former C-level manager of a major airline and a co-founder of a unicorn (a company valued at more than 1 USD billion). We are currently considering raising additional risk capital for further developing BusinessClass.com and creating the world's best search engine for premium travel!

Noroff has campuses in Oslo, Bergen, Stavanger, and Kristiansand. In addition to the Online study capabilities of nearly all study programs. We offer undergraduate degrees in Digital Forensics and Interactive Media with a specialization in either Animation or Games. All our degrees can be completed as a campus student or through online studies. -> We also offer recognition of prior learning, meaning you can be accredited exemption from course subjects based on prior documented education. We offer vocational diploma degrees in Visual Effects (VFX), FrontEnd Development, 3D Design & Animation, Game Design, 3D Films, Sound & Music, Graphic Design, Film Production, Technical Design, Network, and IT. Apply now at www.noroff.no

Vi hjelper våre kunder med å bygge opp en sterk merkevare, laget med god design og valg av riktig teknologi. Vi ønsker nemlig at våre kunder skal bruke tiden på det de er god på, så kan vi ta oss av det vi er eksperter på. Dette gir våre kunder det nødvendige fortrinnet til sine konkurrenter.  Vi er skyldig i morgensdagens løsninger!

Bytt.no er Norges største sammenligningstjeneste for tjenester og produkter innen personlig økonomi. Hver dag bruker tusenvis av nordmenn Bytt.no for å lese verifiserte brukeromtaler om selskaper og sammenligne priser på tusenvis av tjenester og produkter. Vi er en rendyrket IT-bedrift innen fintech og insurtech som digger å løse problemer ved hjelp av ny teknologi. Vårt primære mål er å koble nye kunder med gode bedrifter. Vi jobber med å forenkle, tilgjengeliggjøre og sammenligne tradisjonelt gammeldagse og lite transparente bransjer ved hjelp av teknologi og smarte løsninger. Lyst til å jobbe med oss? Vi har ledige stillinger, sjekk: www.bytt.no/jobb

På YouWish.no finner du Norges største utvalg av opplevelsesgaver. Sammen med landets beste arrangører tilbyr vi flere hundre opplevelsesgaver som du enkelt kan kjøpe i gave til de du er glad i. Med en opplevelsesgave gir du bort kvalitetstid og minner for livet. Vi er stolte av å tilby deg en platform der du trygt, enkelt og raskt kan gi bort minneverdige gaver til den som har alt.

Airmine is a technology company delivering pollen forecasts. Our vision is to help people who are affected by pollen allergies. New ways to deliver pollen forecasts - data-driven and local pollen forecasts, based on weather, topography, vegetation and measurements. We deliver local pollen forecasts as socially useful service.

FeltGIS AS er et teknologiselskap grunnlagt i 2016 og som har spesialisert seg på M2M kommunikasjon og digitale kart. Med et kjerneteam på 7 personer utgjør FeltGIS en unik kombinasjon av spesialisering innenfor GIS-teknologi og mobilkommunikasjon, med lang erfaring fra -og kunnskap om moderne skogsdrift. Selskapet utvikler en digital samhandlingsplattform for planlegging og gjennomføring av hogst, og som digitaliserer rapportering av data for kommersiell anvendelse og ift. miljø- og kvalitetssertifisering. Selskapet har betydelige aktører i bransjen på sin kundeliste. Med FeltGIS sine kart- og datadrevet løsninger får aktørene, private som offentlige, unike muligheter til å optimalisere skogens sirkulære forretningspotensiale og bærekraftige natur ved å dele, samarbeide, og dra nytte av skogkultur, miljø- og produksjonsdata, fra planting til hogst og transport, og videre til resten av næringen.